US Politics
The Risky Gambit: Trump's Cannabis Reclassification and Medicare CBD Proposal
President Trump is expected to sign an executive order reclassifying cannabis from Schedule I to Schedule III and authorizing Medicare coverage for CBD products to treat chronic pain and sleep issues in seniors. This policy, while potentially expanding medical access and research, dangerously prioritizes political and financial interests over scientific rigor, risking elderly health and undermining evidence-based medicine.
